Althea Group Holdings Ltd banner

Althea Group Holdings Ltd
ASX:AGH

Watchlist Manager
Althea Group Holdings Ltd Logo
Althea Group Holdings Ltd
ASX:AGH
Watchlist
Price: 0.017 AUD Market Closed
Market Cap: AU$17m

Althea Group Holdings Ltd
Goodwill

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Althea Group Holdings Ltd
Goodwill Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Goodwill CAGR 3Y CAGR 5Y CAGR 10Y
Althea Group Holdings Ltd
ASX:AGH
Goodwill
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Recce Pharmaceuticals Ltd
ASX:RCE
Goodwill
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mayne Pharma Group Ltd
ASX:MYX
Goodwill
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Goodwill
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Clarity Pharmaceuticals Ltd
ASX:CU6
Goodwill
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vita Life Sciences Ltd
ASX:VLS
Goodwill
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Althea Group Holdings Ltd
Glance View

Market Cap
17m AUD
Industry
Pharmaceuticals

Althea Group Holdings Ltd. is an investment company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2018-09-21. The firm operates through three segments: Australia, United Kingdom and Canada. Australia segment provides technology platform, which is comprised of its on-the-ground Medical Science Liaison team and Althea Concierge, which reduces application times for healthcare professionals prescribed its medicinal cannabis products. The firm distribution and sale of Cannabis 2.0 products including edibles, topicals, and beverages through its subsidiary, Peak Processing Solutions.

AGH Intrinsic Value
HIDDEN
Show

See Also

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett